The chemical substance known as "2H-1,4-Benzodiazepin-2-one, 4-[(5-bromo-2-thienyl)carbonyl]-5-(3,5-dimethylphenyl)-1,3,4,5-tetrahydro-7-methyl-, (5S)-" with CAS number 2561471-15-4 is a complex organic compound that belongs to the benzodiazepine class. This compound features a benzodiazepine core structure, which is characterized by a fused benzene and diazepine ring system. The presence of a thienyl group and a bromo substituent indicates potential for unique electronic and steric properties, which may influence its biological activity. The compound also contains a carbonyl group, suggesting it may participate in various chemical reactions, including nucleophilic attacks. The specific stereochemistry indicated by the (5S) designation implies a particular spatial arrangement of atoms, which can significantly affect the compound's pharmacological properties. Overall, this substance may exhibit interesting interactions with biological targets, making it a candidate for further research in medicinal chemistry and drug development.

2H-1,4-Benzodiazepin-2-one, 4-[(5-bromo-2-thienyl)carbonyl]-5-(3,5-dimethylphenyl)-1,3,4,5-tetrahydro-7-methyl-, (5S)-

2561471-15-4: The chemical substance known as "2H-1,4-Benzodiazepin-2-one, 4-[(5-bromo-2-thienyl)carbonyl]-5-(3,5-dimethylphenyl)-1,3,4,5-tetrahydro-7-methyl-, (5S)-" with CAS number 2561471-15-4 is a complex organic compound that belongs to the benzodiazepine class. This compound features a benzodiazepine core structure, which is characterized by a fused benzene and diazepine ring system. The presence of a thienyl group and a bromo substituent indicates potential for unique electronic and steric properties, which may influence its biological activity. The compound also contains a carbonyl group, suggesting it may participate in various chemical reactions, including nucleophilic attacks. The specific stereochemistry indicated by the (5S) designation implies a particular spatial arrangement of atoms, which can significantly affect the compound's pharmacological properties. Overall, this substance may exhibit interesting interactions with biological targets, making it a candidate for further research in medicinal chemistry and drug development.

<p>SGC6870N is inactive against PRMT6 and can be used as a negative control. It is the inactive enantiomer of SGC6870.</p>

CAS 2561471-15-4

2H-1,4-Benzodiazepin-2-one, 4-[(5-bromo-2-thienyl)carbonyl]-5-(3,5-dimethylphenyl)-1,3,4,5-tetrahydro-7-methyl-, (5S)-

SGC6870N

Ref: TM-T208658